Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | CCR2 | P41597 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | MMP1 | P03956 | 6/20 | 0.33 |
| ▸ | MMP3 | P08254 | 6/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | GBA1 | P04062 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1053481 | 0.78 | KMT2A (0.36) | KMT2ASMN1; SMN2CCR2ALDH1A1MEN1 | |
| SCHEMBL28116056 | 0.74 | KMT2A (0.34) | KMT2ASMN1; SMN2ALDH1A1MEN1MAPK1 | |
| SCHEMBL3621520 | 0.71 | MGLL (0.44) | KMT2ASMN1; SMN2ALDH1A1MEN1 | |
| SCHEMBL9157549 | 0.71 | CYP1A2 (0.43) | KMT2ASMN1; SMN2ALDH1A1MEN1MAPK1 | |
| SCHEMBL28409054 | 0.70 | ALDH1A1 (0.34) | KMT2ASMN1; SMN2ALDH1A1TDP1 | |
| SCHEMBL11845960 | 0.69 | CNR2 (0.46) | SMN1; SMN2ALDH1A1 | |
| SCHEMBL21846702 | 0.67 | ALDH1A1 (0.37) | SMN1; SMN2ALDH1A1 | |
| SCHEMBL23422437 | 0.66 | MEN1 (0.30) | KMT2AALDH1A1MEN1MAPK1TDP1 | |
| SCHEMBL28890261 | 0.66 | ALDH1A1 (0.36) | SMN1; SMN2ALDH1A1 | |
| SCHEMBL11628581 | 0.66 | PDE4A (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2032115-B1 | COMPOSITIONS BASED ON HYPERBRANCHED CONDENSATION POLYMERS AND NOVEL HYPERBRANCHED CONDENSATION POLYMERS | DSM IP ASSETS BV (NL) | 2021-07-21 | — | — | EP | disclosed |
| EP-1991604-B1 | NOVEL HETEROCYCLIC SUBSTITUTED CONDENSATION POLYMERS | DSM IP ASSETS BV (NL) | 2018-03-28 | — | — | EP | disclosed |
| US-8951509-B2 | Heterocyclic substituted condensation polymers | DSM IP ASSETS B.V. (NL) | 2015-02-10 | — | — | US | disclosed |
| US-8394500-B2 | Compositions based on hyperbranched condensation polymers and novel hyperbranched condensation polymers | DSM IP ASSETS B.V. (NL) | 2013-03-12 | — | — | US | disclosed |
| US-20100069601-A1 | COMPOSITIONS BASED ON HYPERBRANCHED CONDENSATION POLYMERS AND NOVEL HYPERBRANCHED CONDENSATION POLYMERS | DSM IP ASSETS B.V. (NL) | 2010-03-18 | — | — | US | disclosed |
| US-20090068124-A1 | NOVEL HETEROCYCLIC SUBSTITUTED CONDENSATION POLYMERS | DSM IP ASSETS B.V. (NL) | 2009-03-12 | — | — | US | disclosed |
| EP-2032115-A2 | COMPOSITIONS BASED ON HYPERBRANCHED CONDENSATION POLYMERS AND NOVEL HYPERBRANCHED CONDENSATION POLYMERS | DSMIP Assets B.V. (NL) | 2009-03-11 | — | — | EP | disclosed |
| EP-1991604-A1 | NOVEL HETEROCYCLIC SUBSTITUTED CONDENSATION POLYMERS | DSMIP Assets B.V. (NL) | 2008-11-19 | — | — | EP | disclosed |
| WO-2007144189-A2 | COMPOSITIONS BASED ON HYPERBRANCHED CONDENSATION POLYMERS AND NOVEL HYPERBRANCHED CONDENSATION POLYMERS | DSM IP ASSETS B.V. (NL) | 2007-12-21 | — | — | WO | disclosed |
| WO-2007098889-A1 | NOVEL HETEROCYCLIC SUBSTITUTED CONDENSATION POLYMERS | DSM IP ASSETS B.V. (NL) | 2007-09-07 | — | — | WO | disclosed |
| US-6730771-B2 | THERMOPLASTIC, THERMOSETTING RESINS | DSM N.V. (NL) | 2004-05-04 | — | — | US | disclosed |
| EP-1171510-B1 | CONDENSATION POLYMER CONTAINING DIALKYLAMIDE ENDGROUPS, PROCESS FOR PRODUCING SAID CONDENSATION POLYMERS AND APPLICATIONS THEREOF | DSM IP ASSETS BV (NL) | 2003-11-05 | — | — | EP | disclosed |
| US-6541110-B2 | Endcapped polyamideester copolymers; compatible blend with another polymer | DSM N.V. (NL) | 2003-04-01 | — | — | US | disclosed |
| US-20020137880-A1 | Condensation polymer containing dialkylamide endgroups, process for producing said condensation polymers and applications thereof | DSM IP ASSETS B.V. (NL) | 2002-09-26 | — | — | US | disclosed |
| US-20020019509-A1 | Condensation polymer containing dialkylamide endgroups, process for producing said condensation polymers and applications thereof | DSM N.V. (NL) | 2002-02-14 | — | — | US | disclosed |
| EP-1038902-A1 | Condensation polymers containing dialkylamide endgroups, process for their production and applications thereof | DSM N.V. (NL) | 2000-09-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090068124-A1 | NOVEL HETEROCYCLIC SUBSTITUTED CONDENSATION POLYMERS | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, ACMSD, C9 | KMT2A 468/4885SMN1; SMN2 1701/4885CCR2 3184/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.